How Europe could have more Biotech Champions like Argenx
For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Argenx is Europe’s most valuable biotech company in 2025. With one approved drug on the market and several more in the pipeline, Argenx is leading the charge in immunology and is addressing significant unmet medical needs.
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.